Firms

Cambridge Enterprise
Cambridge, United Kingdom
Cambridge Enterprise is the University of Cambridge’s commercialisation and early-stage investment subsidiary, legally Cambridge Enterprise Limited, England and Wales company01069886. It supports technology licensing, academic consultancy, venture creation and investments in research spinouts, including AI, deep technology, biotechnology and neuroscience. Cambridge Enterprise Ventures is its internal investment team, formerly Seed Funds, rather than a separately proved external manager or the entire university. Companies House records the legal company’s incorporation on5September1972 and previous name Lynxvale Limited; the university describes its present wholly owned commercialisation structure as established1December2006. These dates describe different legal and operational milestones. Separate subsidiary Cambridge University Technical Services Limited05749230 handles consultancy contracts and has no employees of its own. The directory’s published operating, support, entrepreneurial and board affiliations are scoped to Cambridge Enterprise. Three university evergreen seed funds recycle returns, and the Technology Investment Fund is an internal proof-of-concept programme. University of Cambridge Enterprise Fund EIS series are managed by Parkwalk Advisors in conjunction with Cambridge Enterprise; these partner mandates are distinguished from the internal evergreen funds. Cumulative investment, portfolio values, project commitments and university budget announcements are not represented as external LP fund closes. Primary issuer financing identifies Cambridge Enterprise Ventures as a participant in TRIMTECH’s March2025 seed; existing recipient checks and personal attributions are preserved.
- Founded
- —
- Type
- Venture capital
Funds4
Technology Investment Fund——
Internal university proof-of-concept programme launched2023. GBP10M five-yearbudget and reported3M/4M commitments toprojects are allocated programme funding, not an externally closed LPcorpus or actual aggregate paid cash. Fundamount/closingdayNULL; supports translationalsoftware, therapeutics/devices/materials projects.
University Challenge Fund—£4M
University evergreen seed fund established2000; original primary2009review reportsGBP4M actual fundsize, fullyinvested withreturnsavailable forreinvestment. Historicalcorpus not a new2026 LPclose; exact closingday unpublishedNULL.
University of Cambridge Discovery Fund—£1M
University evergreen fund financed by charitable donations, established2008. Own2025review identifies originalGBP1.8M donatedcorpus;47companies supported/8.6Mreturned describe investmentresults not newcashfundraises. Earlier2009raised1.3M vs5Mtarget is historicalprogress, not a duplicate closed fund. Exact final donationdate unpublishedNULL.
University Venture Fund——
University evergreen seed fund established1995, managed through Cambridge Enterprise; reinvests realised proceeds. Own2009annualreview reports historicalGBP2.4M fundsize, not a current externalLPcashclose. Precise original paid-cash corpus/day not established; amount/dateNULL.
Team
Operations and support
Abdulmalik Abdullahi ShinkafiAI Integration Engineer |
Abigail SwadlingFinance Business Partner |
Ajay ChowdhuryBoard Chairman |
Alessandro CoppolaAssistant Finance Business Partner |
Alexander SeddonAssociate Commercialisation Manager (Consultancy) |
Alexandra Canet FontCommunications Director |
Amanda WoodingDeputy Head of Ventures |
Amanda ZeffmanHead of Consultancy Services and Research Tools |
Amy LamSenior Commercialisation Manager (Life Sciences) |
Amy ReedPost Deal Manager |
Anca WeldonIT Support Analyst |
Angeline GunaseelanIP Portfolio Coordinator (Life Sciences) |
Anna WaldockAdministrative Team Lead (TD&L) |
Annalisa GiganteExternal Non-Executive Director |
Anne SablonniereCommercialisation Manager (Consultancy) |
Annika FribergSenior Commercialisation Associate (Life Sciences) |
Anthony OdgersUniversity Non-Executive Director |
Arnie PatelSenior Commercialisation Manager (Life Sciences) |
Ben AlexanderExternal Non-Executive Director |
Ben HartleyDirector of ideaSpace |
Billy DaviesAssociate Commercialisation Manager (Research Tools) |
Boris BouqueniauxHead of Business Support |
Caroline HydeHead of Entrepreneurship and Ecosystems |
Catherine EyreSenior Commercialisation Manager (Agri-Tech) CERES |
Chris NuttIT Systems and Security Manager |
Christine MartinHead of Ventures |
Christine WatermanVentures PA and Data Administrator |
Connor FarrellManager, Early Talent |
Dafne ChirivinoAssociate Business Development Director (Life Sciences) |
Daisy WraightBusiness Administration Apprentice |
Dan DrewSenior Business Intelligence Developer |
Daniela LoboTechnology Development & Project Manager |
David WalshHead of IT |
David WashburnExternal Non-Executive Director |
Debu PurkayasthaExternal Non-Executive Director |
Declan WeldonHead of Technology Development & Licensing |
Denise ChampionBusiness Support Coordinator (AHSS) |
Diane GaskinHead of Finance |
Dominic ChiversCommercialisation Manager (Arts, Humanities and Social Sciences) |
Elizabeth BoneFinancial Accountant |
Ellie GreatorexEvents Manager |
Ellie ReidAssociate Commercialisation Manager (Physical Sciences) |
Ellie ThompsonCommercialisation Associate (Arts, Humanities and Social Sciences) |
Emily TurnerSenior Marketing and Communications Executive |
Emma GarfieldSenior Commercialisation Manager (Agri-Tech) CERES |
Emma LawrenceSenior Commercialisation Manager (Life Sciences) |
Emma Salgård CunhaDirector of DeepTech & Software |
Eva MaciagEvents & Creative Executive |
Farah Al-NaimiAssociate Director (Physical Sciences) |
Francesca MelleSenior Commercialisation Associate (Research Tools) |
Gemma SiddallSenior Investment Associate (Sustainability) |
Georgina HallEIP Events and Administration Lead |
Gianluca D’UvaSenior Marketing and Communications Executive |
Gillian DavisCommercialisation Director, Deputy Head of Physical Sciences |
Hannah PapeAssociate Manager (Life Sciences) |
Helen AlexanderDirector of IE Cambridge |
Helen AtkinsonDeputy Head of Consultancy Services |
Helen YoungCommercialisation Manager (Life Sciences) |
Helena Did-DellAdministrative Team Lead (Consultancy & Research Tools) |
Ian EverettArtificial Intelligence Lead |
Ione MeyerSenior Commercialisation Manager (Life Sciences) |
Isak OuariacheJunior Business Intelligence Analyst |
Jack DaviesOperations Associate |
James CampCommercialisation Associate (Life Sciences) |
Jason AmarteyInvestment Analyst |
Jennie FlintAssociate Commercialisation Director (Physical Sciences) |
Jennifer BromleyCommercialisation Manager (Agri-tech) CERES |
Jim GlasheenChief Executive |
Joanna TramontinHead of Marketing and Communications |
John AstonUniversity Non-Executive Director |
Julie BoultonPost Deal Coordinator |
Kara WellsMarketing and Communications PA |
Kate DulwichAssociate Business Development Manager (Life Sciences) |
Kerry WaltonExecutive Assistant to CEO |
Kimberley MensahPeople Lead |
Kirsten BatchelerMembership, Marketing and Office Manager (ideaSpace City) |
Kirsty LattoCommercialisation Manager (Consultancy) |
Laura Diaz AnadonAcademic Non-Executive Director |
Laura DonnellyAssociate Director (Life Sciences) |
Laura EscobarTenU Team Assistant |
Laura SkinnerPA & Strategic Projects Support, EIP |
Leila GuichardMarketing & Events Director |
Leila KarassParalegal |
Lewis KearseySenior Commercialisation Associate (Life Sciences) |
Lexi Radcliffe-HartCommunications Manager (Digital) |
Leyla GezerMid-Weight Designer |
Lore LippmannChief Financial Officer |
Louise SutherlandCeres Project Development Director |
Magda AliSenior Commercialisation Associate (Consultancy) |
Mahesh SantiapillaiInvestment Manager (Software & DeepTech) |
Maitena Fernandez GonzalezOffice and Events Manager (ideaSpace West) |
Maria AspiotiTechnology Development & Project Manager |
Marina Avena MaiaSenior Commercialisation Associate (Physical Sciences) |
Marina Gonzalo SoaresGlobal Outreach Manager |
Maruf AhmedIT Support Analyst |
Matt DoorbarLegal Counsel |
Matt WellsSenior Commercialisation Associate (Physical Sciences) |
Matthew NewmanAssociate Director (Physical Sciences) |
Matthew WheelerCredit Controller |
Megan Meredith-RodriguezInvestment Associate (Deep Tech) |
Mei HongSenior Commercialisation Associate (Physical Sciences) |
Michael YardleyIT Support Manager |
Michelle Zappala WoodHead of People and Culture |
Morag NixonSenior Commercialisation Associate (Life Sciences) |
Natalie KirschIP Coordination Team Lead (Physical Sciences) |
Nathalie MullerSenior Commercialisation and Outreach Manager (Physical Sciences) |
Oakley CarrSenior Global Outreach Executive |
Oleksandra KorychenskaTechnology Development & Project Manager |
Oliver PaulGlobal Outreach Manager |
Patrick MaxwellAcademic Non-Executive Director |
Paul SeabrightExecutive Director |
Peri CihanAssociate Director (Consultancy) |
Phil ElstobSenior Commercialisation Director (LS) |
Piers HorlockInvestment Associate |
Pippa BrowneSenior Strategic Communications Advisor (TenU) |
Poppy NicholsonTechnology Development & Licensing PA |
Rachel AtfieldAssociate Director (Life Sciences) |
Richard BrownApplication Manager |
Richard PalmerEnterprise Education Lead |
Rosemary BoyleGeneral Counsel (Intellectual Property) |
Róisín OwensAcademic Non-Executive Director |
Samuel DaffernSenior Translation Associate |
Sarah Ranchev-HaleDirector of Entrepreneurship |
Saran Mullen-YatesOperations Manager |
Sinead VarleyOffice & Facilities Manager |
Siân FogdenAssociate Director (Research Tools) |
Sofia Spiegel-RenshawOperations Assistant |
Sophie ApplebyOperations and Project Manager (ideaSpace West) |
Sophie JonesSenior Commercialisation Associate (Physical Sciences) |
Stefan GalanderInvestment Associate |
Steven HummFinance Administrator |
Susan HandsPurchase Ledger Administrator |
Suzy DillyAssociate Director (Life Sciences) |
Tania Gonzalez DuranSenior Commercialisation Associate (Consultancy) |
Tegen AmosCreative Manager |
Terry ParlettSenior Commercialisation Director (LS) |
Tom MentlakHead of Technology Investment Fund |
Usman MunirCommercialisation Manager (Deeptech & Software) |
Vicky McDonnellVentures PA |
Winny SanchitaManager, Accelerator |
Yu Zhou (Angelina)Marketing & Partnerships Executive |
Yvette EdwardsSenior Administration Coordinator (Consultancy Services & Research Tools) |
Zoe ParrySenior Commercialisation Associate (Life Sciences) |
Co-investing
ARCH Venture Partners
Pretzel Therapeutics$72M · 2022-09-12
Carrick Therapeutics$95M · 2016-10-03
Cambridge Innovation Capital
TRIMTECH Therapeutics$31M · 2025-03-05
Carrick Therapeutics$95M · 2016-10-03
GV
Pretzel Therapeutics$72M · 2022-09-12
Carrick Therapeutics$95M · 2016-10-03
Pretzel Therapeutics$72M · 2022-09-12
Amadeus Capital Partners
Nu Quantum$— · 2023-11-03
Angelini Ventures
Pretzel Therapeutics$72M · 2022-09-12
APEX Ventures
Zetta Genomics$— · 2024-02-08
Transition Bio$50M · 2022-06-02
Creator Fund
Tenyks$3M · Unknown date
Dementia Discovery Fund
TRIMTECH Therapeutics$31M · 2025-03-05
Eli Lilly and Company
TRIMTECH Therapeutics$31M · 2025-03-05
Expeditions
Nu Quantum$— · 2023-11-03
Tenyks$3M · Unknown date
Pretzel Therapeutics$72M · 2022-09-12
IQ Capital
Nu Quantum$— · 2023-11-03
James Glyn Thomas
Trismik£2M · 2025-09-24
Transition Bio$50M · 2022-06-02
Carrick Therapeutics$95M · 2016-10-03
M Ventures
TRIMTECH Therapeutics$31M · 2025-03-05
Magnetic Ventures
Transition Bio$50M · 2022-06-02
Michael Anstey
TRIMTECH Therapeutics$31M · 2025-03-05
MP Healthcare Venture Management
TRIMTECH Therapeutics$31M · 2025-03-05
Nu Quantum$— · 2023-11-03
Nina Capital
Zetta Genomics$— · 2024-02-08
Northpond Ventures
Transition Bio$50M · 2022-06-02
NovaCapital (Italy)
Zetta Genomics$— · 2024-02-08
Parkwalk Advisors
Trismik£2M · 2025-09-24
Pfizer Ventures
TRIMTECH Therapeutics$31M · 2025-03-05
Phoenix Sustainable Investments
Upfront Diagnostics$4M · 2025-05-12
Primary Venture Partners
Carrick Therapeutics$95M · 2016-10-03
Nu Quantum$— · 2023-11-03
Speedinvest
Tenyks$3M · Unknown date
Start Codon
TRIMTECH Therapeutics$31M · 2025-03-05
Taiho Ventures
Transition Bio$50M · 2022-06-02
Twin Path Ventures
Trismik£2M · 2025-09-24
Ventures Together
Trismik£2M · 2025-09-24
We Venture Capital
Zetta Genomics$— · 2024-02-08
Y Combinator
Tenyks$3M · Unknown date

















































































































































